Working along side an international team of researchers, Insception Lifebank board members, Dr. Ian Rogers and Dr. Nagy, identified a new type of stem cells that could be instrumental in the generation of safer and more efficient designer cells used in therapy.
Headed by Dr. Nagy, the project is dubbed ‘Project Grandiose’, a nod to the massive scale of the team’s undertaking. The discovery was announced via simultaneous publication of five scientific articles in the journals, Nature and Nature Communications. Professor Jim Woodgett, Lunenfeld’s director and a professor in U of T’s department of medical biophysics notes, “These papers reinforce how strategic investment in the best scientific research can truly transform our understanding and lead to new therapeutic possibilities”.
The discovery made news around the world, capturing the public’s imagination with the promise it holds for the treatment of currently incurable diseases. (See the CBC coverage; read the Toronto Star article; read the TIME magazine article; read The Australian’s coverage.)
Driven by a desire to improve the quality of treatment for patients, the team of nearly 50 scientists worked together tirelessly to “contribute to a unified product which none of [them] as individuals could even get close to”.
This incredible discovery reinforces the incalculable value of stem cells and the importance of investing in your baby’s and your family’s future by banking stem cell rich cord blood and cord tissue. Take the first step – learn more about banking with Insception Lifebank.